Launch of New Agents with Niche Roles Will Contribute to Drug Market Growth in the Treatment of Non-Muscle-Invasive Bladder Cancer

BURLINGTON, Mass.--(BUSINESS WIRE)--Allergan/Spectrum Pharmaceuticals’ EOquin Will Carve Out a Niche for Itself in the Immediate Postoperative Setting According to Decision Resources Report

Feed Date: 
February 14, 2012